Chronic obstructive pulmonary disease: Current burden and future projections

European Respiratory Journal

Volumn 27, Issue 2, 2006, Pages 397-412

  Lopez, A D ^a   Shibuya, K ^b   Rao, C ^a   Mathers, C D ^b   Hansell, A L ^c   Held, L S ^d   Schmid, V ^d   Buist, S ^e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d UNIVERSITY OF MUNICH   (Germany)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; BAYES THEOREM; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE DURATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HUMAN; INCIDENCE; MALE; MORTALITY; NORTH AMERICA; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; SPIROMETRY; SYMPTOMATOLOGY; UNITED KINGDOM;

COST OF ILLNESS; EPIDEMIOLOGIC METHODS; FORECASTING; HUMANS; MODELS, STATISTICAL; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; WORLD HEALTH;

EID: 31844435204     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00025805     Document Type: Article

References (71)

1. Murray CJ, Lopez AD. The Global Burden of Disease. Boston, Harvard School of Public Health, Harvard University Press, 1996.
2. DisMod version 1.0. Release note. Global Programme on Evidence for Health Policy. Geneva, World Health Organization, 2001.
3. Murray CJ, Lopez AD, Mathers CD, Stein C. The Global Burden of Disease 2000 Project: aims, methods, and data sources. Global Programme on Evidence for Health Policy, Discussion paper #36. Geneva, World Health Organization, 2001.
4. Mathers C, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died of: an assessment of the global status of cause of death data. Bull World Health Organ 2005; 83: 171-177.
5. Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997; 156: 814-818.
6. Salomon JA, Murray CJL. The epidemiological transition revisited: compositional models for causes of death by age and sex. Popul Dev Rev 2002; 28: 205-228.
7. World Health Organization. World Health Report, 2004: Changing History. Geneva, World Health Organization, 2004.
8. Yang G, Jianping H, Kequin R, Ma J, Rao C, Lopez AD. Mortality registration and surveillance in China: history, current situation and challenges. Popul Health Metr 2005; 3: 3.
9. Chen JC, Mannino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med 1999; 5: 93-99.
10. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269-280.
11. Hurd S. The impact of COPD on lung health worldwide. Chest 2000; 117: Suppl. 2, 1S-4S.
12. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
13. Petty TL. Definitions, causes, and prognosis of chronic obstructive pulmonary disease. Respir Care Clin N Am 1998; 4: 345-358.
14. Rennard SI. COPD: overview of definitions, epidemiology, and factors influencing its development. Chest 1998; 113, Suppl. 4, 2355-241S.
15. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States. Arch Intern Med 2000; 160: 1683-1689.
16. Barendregt JJ, Baan CA, Bonneux L. An indirect estimate of the incidence of non-insulin-dependent diabetes mellitus. Epidemiology 2000; 11: 274-279.
17. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 33: 14-20.
18. Burrows B, Bloom JW, Trayer GA, Cline MG. The course and prognosis of different forms of chronic airway obstruction in a sample from the general population. N Engl J Med 1987; 317: 1309-1314.
19. Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1990; 1: 555-569.
20. Sherrill DL, Lebowitz MD, Burrows B. Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med 1990; 11: 375-387.
21. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268-1278.
22. Behera D, Jindal SK. Respiratory symptoms in Indian women using domestic cooking fuels. Chest 1991; 100: 385-388.
23. Dennis RJ, Maldonado D, Norman S, et al. Wood smoke exposure and risk for obstructive airways disease among women. Chest 1996; 109: Suppl. 3, 55S-56S.
24. Saldiva PH, Pope CA 3rd, Schwartz J, et al. Air pollution and mortality in elderly people: a time-series study in Sao Paulo, Brazil. Arch Environ Health 1995; 5: 159-163.
25. Ezzati M, Lopez AD, Rodgers A, Murray CJL. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva, World Health Organization, 2004.
26. Hnizdo E. Health risks among white South African goldminers: dust, smoking, and chronic obstructive pulmonary disease. S Afr Med J 1992; 81: 512-517.
27. Pandy MR. Prevalence of chronic bronchitis in a rural community of the hill region of Nepal. Thorax 1984; 39: 337-339.
28. Mahler DA. How should health-related quality of life be assessed in patients with COPD? Chest 2000; 117: Suppl. 2, 54S-57S.
29. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648.
30. Wise RA. Changing smoking patterns and mortality from chronic obstructive pulmonary disease. Prev Med 1997; 26: 418-421.
31. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
32. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-1289.
33. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348: 1115-1119.
34. Finnerty JP, Keeping I, Bullough I, Jones J. The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease. A randomised trial. Chest 2001; 119: 1705-1710.
35. Jans MP, Schellevis FG, Le Coq EM, Bezemer PD, van Eijk JTM. Health outcomes of asthma and COPD patients: the evaluation of a project to implement guidelines in general practice. Int J Qual Health Care 2000; 13: 17-25.
36. Geddes D, Davies M, Koyama H, et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med 2000; 343: 239-245.
37. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003; 123: 1684-1692.
38. Tan WC, Seale JP, members of the Regional COPD Working Group. COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model. Respirology 2003; 8: 192-198.
39. Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Molken MP. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001; 164: 590-596.
40. Miller N, Simoes EJ, Chang JC, Robling AG. Trends in chronic obstructive pulmonary disease mortality. Mo Med 2000; 97: 87-90.
41. Osmond C. Using age, period and cohort models to estimate future mortality rates. Int J Epidemiol 1985; 14: 124-129.
42. Lee PN, Fry JS, Forey BA. Trends in lung cancer, chronic obstructive lung disease and emphysema death rates for England and Wales 1941-85 and their relation to trends in cigarette smoking. Thorax 1990; 45: 657-665.
43. Osmond C, Gardner MJ. Age, period and cohort models applied to cancer mortality rates. Stat Med 1982; 1: 245-259.
44. Osmond C, Barker DJP. Ischaemic heart disease in England and Wales around the year 2000. J Epidemiol Community Health 1991; 45: 71-72.
45. Brown CC, Kessler LG. Projections of lung cancer mortality in the United States: 1985-2025. J Natl Cancer Inst 2004; 80: 43-51.
46. Bray I, Brennan P, Boffetta P. Projections of alcohol- and tobacco-related cancer mortality in central Europe. Int J Cancer 2000; 87: 122-128.
47. Bray I, Brennan P, Boffetta P. Recent trends and future projections of lymphoid neoplasms: a Bayesian age-period-cohort analysis. Cancer Causes Control 2001; 12: 813-820.
48. Bray I, Brennan P. Recent trends and future directions for lung cancer mortality. Br J Cancer 2002; 87: 43-48.
49. Knorr-Held L, Rainer E. Prognosis of lung cancer mortality in West Germany: a case study in Bayesian prediction. Biostatistics 2001; 2: 109-129.
50. Office for National Statistics. Twentieth Century Mortality CD-ROM (Crown Copyright). London, Office for National Statistics, 1997.
51. Office for National Statistics. Office for National Statistics Twentieth Century Mortality Files 1996 Update Disk. London, Office for National Statistics, 1998.
52. Office for National Statistics. Mortality statistics, cause. Review of the Registrar General on deaths by cause, sex and age, in England and Wales, 1997. 24 Edn. London, The Stationery Office, 1998.
53. Office for National Statistics. Mortality statistics, cause. Review of the Registrar General on deaths by cause, sex and age, in England and Wales, 1998. 25th Edn. London, The Stationery Office, 1999.
54. Office for National Statistics. Mortality statistics, cause. Review of the Registrar General on deaths by cause, sex and age, in England and Wales, 1999. 26th Edn. London, The Stationery Office, 2000.
55. Smyth ET, Wright SC, Evans AE, Sinnamon DG, MacMahon J. Death from airways obstruction: accuracy of certification in Northern Ireland. Thorax 1996; 51: 293-297.
56. Marks G, Burney P. Diseases of the respiratory system. In: Charlton J, Murphy M, eds. The health of adult Britain 1841-1994. London, The Stationery Office, 1997; pp. 93-113.
57. The Registrar General's Statistical Review of England & Wales for the year 1957. Part III, commentary. London, Her Majesty's Stationery Office, 1959.
58. The Registrar General's Statistical Review of England & Wales for the year 1957. Part I, Tables, Medical. London, Her Majesty's Stationery Office, 1959.
59. The Registrar General's Statistical Review of England & Wales for the year 1967. Part I. Tables, Medical. London, Her Majesty's Stationery Office, 1969.
60. The Registrar General's Statistical Review of England & Wales for the year 1967. Part III, commentary. London, Her Majesty's Stationery Office, 1971.
61. Bayesian Age-Period-Cohort Modelling and Prediction (BAMP; version 1.3.0; December 14, 2004). Ludwig-Maximilians-Universität, Munich, German, 2002. www.statistik.lmu.de/sfb386/software/bamp/bamp/. Date last accessed: December 22 2005.
62. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 1987; 6: 469-481.
63. Berzuini C, Clayton D, Bernardinelli L. Bayesian inference on the lexis diagram. Bull Int Stat Inst 1993; 50: 149-164.
64. Hansell AL, Knorr-Held LS, Schmid VH. Projecting respiratory mortality with a Bayesian age-period-cohort model. Am J Respir Crit Care Med 2003; 167: Suppl. 7, A683.
65. Richardson S, Thomson A, Best N, Elliott P. Interpreting posterior relative risk estimates in disease-mapping studies. Environ Health Perspect 2004; 112: 1016-1025.
66. Bohadana A, Teculescu D, Martinet Y. Mechanisms of chronic airway obstruction in smokers. Respir Med 2004; 98: 139-151.
67. Wald N, Nicolaides-Bouman A. UK Smoking Statistics. 2nd Edn. Oxford, Oxford University Press, 1991.
68. Devis T, Rooney C. Death certification and the epidemiologist. Health Statistics Quarterly 1999; 1: 25-33.
69. Bray I. Application of Markov chain Monte Carlo methods to projecting cancer incidence and mortality. J R Stat Soc Ser C Appl Stat 2002; 51: 151-164.
70. Hansell AL, Walk JA, Soriano JB. What do COPD patients die from? A multiple cause coding analysis for England & Wales. Eur Respir J 2003; 22: 809-814.
71. Camilli AE, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991; 133: 795-800.